Dr. Christopher Yallop is a member of the Management Committee of Batavia Biosciences.
Prior to that he was at TNO where he assumed the position of Head of biopharmaceutical development. From 2002 to 2008 he was Director and subsequently Senior Director Protein R&D at Crucell, The Netherlands. From 1996 to 2002 he was Senior Scientist Protein development at Novo Nordisk in Denmark. Prior to that he assumed positions at GSK and Genzyme. He holds a PhD degree from the University of Liverpool, United Kingdom.
Within Batavia Biosciences Chris is responsible for the operational and scientific direction of the company.